Celiac Disease May Be a Little-Known Complication of Mesothelioma Immunotherapy
A new French case report shines a spotlight on a little-known potential complication of mesothelioma immunotherapy: celiac disease. Celiac disease is a chronic digestive and immune disorder brought on by sensitivity to gluten. Over time, celiac disease damages the small intestine causing long-lasting digestive problems. It can prevent patients from getting the nutrients they need to stay healthy. The new case report appears in Frontiers in Immunology. It details the case of a 70-year-old man who developed celiac disease after treatment with nivolumab. The case suggests that celiac disease may be an underrecognized side effect of mesothelioma immunotherapy. It is a reminder for mesothelioma patients and doctors to pay close attention to digestive problems after treatment. Stimulating the Immune System…